ARCHIVES

In Brief: Kennedy, Waxman May Agree On Simple Extension Of Biomedical Research Authority, Including NCI

This article is from The Cancer Letter archive.

Vol. 06 No. 46 | November 21, 1980

Download PDF Visit The Full Archive

Related Articles

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds

March 28, 2003

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978